Alopecia areata, an autoimmune disorder causing hair loss, now has an FDA-approved treatment since June 2022. While some ...

Alopecia areata, characterized by patchy hair loss, prompts many to seek natural remedies. Scalp massages with essential oils ...

Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune ...

Alopecia areata, an autoimmune condition, leads to patchy hair loss due to immune system attacks on hair follicles. Garlic, ...

Sun Pharmaceutical Industries, announced its release of Leqselvi in the U.S. earlier this week. Leqselvi™ is currently ...

LEQSELVI has shown rapid results in clinical trials, with one-third of patients regaining nearly full scalp hair by Week 24.

LEQSELVI has been approved by the US FDA, following strong results from clinical trials and is now available to adults ...

You might associate autoimmune conditions with symptoms like skin disease, chronic pain, and fatigue. A less-discussed ...

Sun Pharmaceutical Industries Limited announced Leqselvi (deuruxolitinib) 8 mg tablets is now available to healthcare providers and people living with severe alopecia areata in the US. Leqselvi is ...

Discover 6 shocking truths about sudden hair loss and alopecia areata. Learn life-changing strategies that restore confidence and promote regrowth.

Mumbai: Sun Pharmaceutical Industries Limited has announced the launch of LEQSELVI (deuruxolitinib) 8 mg tablets in the U.S.

"The launch of LEQSELVI in the U.S. brings an effective, new treatment option for severe alopecia areata to eligible patients and the healthcare providers who treat them," said Richard Ascroft, CEO, ...